FR2215972A1 - - Google Patents

Info

Publication number
FR2215972A1
FR2215972A1 FR7403658A FR7403658A FR2215972A1 FR 2215972 A1 FR2215972 A1 FR 2215972A1 FR 7403658 A FR7403658 A FR 7403658A FR 7403658 A FR7403658 A FR 7403658A FR 2215972 A1 FR2215972 A1 FR 2215972A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7403658A
Other languages
French (fr)
Other versions
FR2215972B1 (ja
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richardson Vicks Inc
Original Assignee
Richardson Merrell Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Merrell Inc filed Critical Richardson Merrell Inc
Publication of FR2215972A1 publication Critical patent/FR2215972A1/fr
Application granted granted Critical
Publication of FR2215972B1 publication Critical patent/FR2215972B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0025—Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0029—Ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/0037—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/004—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0044—Alkenyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/004—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0048—Alkynyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
FR7403658A 1973-02-05 1974-02-04 Expired FR2215972B1 (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32984973A 1973-02-05 1973-02-05

Publications (2)

Publication Number Publication Date
FR2215972A1 true FR2215972A1 (ja) 1974-08-30
FR2215972B1 FR2215972B1 (ja) 1977-05-06

Family

ID=23287276

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7403658A Expired FR2215972B1 (ja) 1973-02-05 1974-02-04

Country Status (7)

Country Link
AU (1) AU472681B2 (ja)
BE (1) BE810457A (ja)
DE (1) DE2404332A1 (ja)
FR (1) FR2215972B1 (ja)
GB (1) GB1450439A (ja)
PH (1) PH11122A (ja)
ZA (1) ZA739584B (ja)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB820779A (en) * 1954-12-08 1959-09-23 Syntex Sa Cyclopentanophenanthrene derivatives
FR1374356A (fr) * 1962-05-16 1964-10-09 Syntex Corp Procédé de préparation de dérivés du cyclopentanophénanthrène
NL6406949A (ja) * 1963-06-19 1964-12-21

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB820779A (en) * 1954-12-08 1959-09-23 Syntex Sa Cyclopentanophenanthrene derivatives
FR1374356A (fr) * 1962-05-16 1964-10-09 Syntex Corp Procédé de préparation de dérivés du cyclopentanophénanthrène
NL6406949A (ja) * 1963-06-19 1964-12-21

Also Published As

Publication number Publication date
FR2215972B1 (ja) 1977-05-06
AU472681B2 (en) 1976-06-03
GB1450439A (en) 1976-09-22
ZA739584B (en) 1974-11-27
BE810457A (fr) 1974-05-16
AU6397673A (en) 1975-07-03
DE2404332A1 (de) 1974-08-08
PH11122A (en) 1977-10-27

Similar Documents

Publication Publication Date Title
AU465372B2 (ja)
AU474593B2 (ja)
AU474511B2 (ja)
AU474838B2 (ja)
AU465453B2 (ja)
AU471343B2 (ja)
AU450229B2 (ja)
AU476714B2 (ja)
FI53707B (ja)
FR2223014A1 (ja)
AU472848B2 (ja)
AU466283B2 (ja)
AU476696B2 (ja)
AU477823B2 (ja)
FR2215972B1 (ja)
AU461342B2 (ja)
AU476873B1 (ja)
AU471461B2 (ja)
AU477824B2 (ja)
CH559791A5 (ja)
BG19251A1 (ja)
AU479521A (ja)
AU479504A (ja)
AU479496A (ja)
AU479458A (ja)

Legal Events

Date Code Title Description
ST Notification of lapse